Work

Clinical outcomes of patients with TP53 pathway alterations by treatment type: The MD Anderson Cancer Center IMPACT 2 study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3152

Authors: Jacopo Venturini, Mehmet A. Baysal, Abhijit Chakraborty, Siqing Fu, David S. Hong, Sarina A. Piha-Paul, Aung Naing, Jordi Rodon Ahnert, Timothy A. Yap, Ecaterina Elena Dumbrava, Jennifer Beck, Clark Andersen, Michael Kahle, David J. Vining, Funda Meric-Bernstam, Apostolia Maria Tsimberidou

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Foundation Medicine

OpenAlex ID: W7162494905

Cites:

Cited by:

Related to: